NCT03130426 Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi Status COMPLETED Phase PHASE3
NCT03123757 Assessing the Determinants of 6-minute Walk Test and Its Correlation With Quality of Life Status COMPLETED Phase NA
NCT03114254 A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis Status COMPLETED Phase PHASE2
NCT03099213 An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event Status COMPLETED Phase PHASE4
NCT03099122 A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant Status COMPLETED Phase PHASE4
NCT03088540 Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT03070678 Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT03069963 PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT03066830 Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin Status COMPLETED Phase PHASE3
NCT03065816 Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT03063580 Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin Status COMPLETED Phase PHASE1
NCT03057470 Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT) Status UNKNOWN Phase PHASE4
NCT03054727 Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) Status COMPLETED Phase N/A
NCT03054428 Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03050866 Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs) Status UNKNOWN Phase PHASE2
NCT03050151 Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT03043729 mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer Status COMPLETED Phase PHASE2